Anti-Procainamide [Clone PC10-138.2]
Anti-Procainamide [Clone PC10-138.2]
Product No.: 16701
Data
These antibodies recognize procainamide and cross-react to different degrees with N-Acetylprocainamide.
Procainamide is an antiarrhythmic used to treat cardiac arrhythmias. - -
- -
Antibody DetailsProduct DetailsReactive Species Procainamide Host Species Mouse Immunogen Procainamide-KLH. Product Concentration Lot Specific Formulation This monoclonal antibody is formulated in phosphate buffered saline (PBS) pH 7.2 - 7.4 with no carrier protein or preservatives added. State of Matter Liquid Product Preparation Antibodies are purified by a multi-step process including the use of PEG purification chromatography. Storage and Handling This antibody is stable for at least one (1) year at -20°C to -70°C. Store product in appropriate aliquots to avoid multiple freeze-thaw cycles. Country of Origin USA Shipping Next Day 2-8°C Applications and Recommended Usage? Quality Tested by Leinco These antibodies have been qualified for use in ELISA to detect procainamide. Each investigator should determine their own optimal working dilution for specific applications. See directions on lot specific datasheets, as information may periodically change. DescriptionDescriptionSpecificity This mouse monoclonal antibody is specific to procainamide and shows 8.4% cross-reactivity with N-acetylprocainamide . Background Procainamide is an antiarrhythmic used to treat cardiac arrhythmias. It induces rapid block of the batrachotoxin (BTX)-activated sodium channels of the heart muscle and acts as antagonist to long gating closures. Procainamide is metabolized via different pathways. The most common one is the acetylation of procainamide to the less toxic N- acetylprocainamide. Procainamide was approved by the US FDA on June 2, 1950. Research Area Drugs References & CitationsTechnical Protocols Certificate of Analysis |
Formats Available
Products are for research use only. Not for use in diagnostic or therapeutic procedures.
